| Recruiting | A Study of the Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple Sclerosis Relapsing-remitting Multiple Sclerosis (RRMS) | Phase 3 | 2025-11-01 |
| Recruiting | Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in S Crohn's Disease (CD) | Phase 2 | 2025-08-14 |
| Recruiting | Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects W Ulcerative Colitis (UC) | Phase 2 | 2025-08-14 |
| Recruiting | Safety, Pharmacokinetics, Immunogenicity BCD-256-1 and Divozilimab in Subjects With Systemic Lupus Erythematos Systemic Lupus Erthematosus | Phase 1 | 2025-03-27 |
| Recruiting | A Study of Pharmacokinetics, Safety, and Immunogenicity of BCD-057 100 mg/mL, BCD-057 50 mg/mL, and Humira 100 Healthy Adult Male | Phase 1 | 2025-03-12 |
| Recruiting | Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic K Anemia, Chronic Kidney Disease, Chronic Kidney Disease Patients on Hemodialysis | Phase 3 | 2025-03-01 |
| Recruiting | An Open-Label Clinical Study of the Efficacy and Safety of BCD-248 in Patients With Relapsed/Refractory Multip Relapsed/Refractory Multiple Myeloma | Phase 2 | 2024-12-26 |
| Recruiting | An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Pat Hemophilia B | Phase 3 | 2024-11-07 |
| Active Not Recruiting | Study of the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of Netakimab in Children With Moderate to Plaque Psoriasis | Phase 3 | 2024-08-08 |
| Recruiting | BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Ca Triple Negative Breast Cancer | Phase 2 | 2024-07-15 |
| Recruiting | Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Ascending Doses BCD-261 in Healthy Subjects Healthy | Phase 1 | 2024-03-29 |
| Active Not Recruiting | Clinical Study of the Efficacy and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Mela Advanced Melanoma, Melanoma (Skin) | Phase 3 | 2024-03-21 |
| Active Not Recruiting | Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyl Axial Spondyloarthritis | Phase 3 | 2023-12-25 |
| Recruiting | A Study of the Efficacy and Safety of Monotherapy With BCD-264 and Darzalex in Subjects With Relapsed and Refr Multiple Myeloma | Phase 3 | 2023-12-21 |
| Active Not Recruiting | A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A Hemophilia A | Phase 1 / Phase 2 | 2023-07-26 |
| Active Not Recruiting | A Clinical Study of the Pharmacokinetics and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Adv Advanced Melanoma | Phase 1 | 2023-05-29 |
| Completed | A Study to Assess the PK, PD, Safety and Immunogenicity of Single IV Infusion of BCD-264 and Darzalex in Healt Healthy | Phase 1 | 2023-05-17 |
| Recruiting | Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN) Hemophilia B | Phase 1 / Phase 2 | 2023-05-02 |
| Active Not Recruiting | A Study of Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With Resectable Stage III Sk Melanoma Stage III, Melanoma (Skin) | Phase 3 | 2023-04-05 |
| Recruiting | Study of the Safety and Efficacy of an Adeno-Associated Viral Vector Carrying the SMN Gene After a Single Intr Spinal Muscular Atrophy (SMA) | Phase 1 / Phase 2 | 2023-02-02 |
| Active Not Recruiting | Clinical Study of the Efficacy and Safety of BCD-178 and Perjeta® as Neoadjuvant Therapy of HER2-Positive Brea Breast Cancer | Phase 3 | 2023-01-30 |
| Active Not Recruiting | Clinical Study of Divozilimab in Patients With Systemic Scleroderma Systemic Scleroderma | Phase 3 | 2022-12-26 |
| Active Not Recruiting | Efficacy and Safety of Divozilimab in Patients With Neuromyelitis Optica Spectrum Disorders (AQUARELLE) Neuromyelitis Optica Spectrum Disorders | Phase 3 | 2022-12-12 |
| Active Not Recruiting | A Two-Stage Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics and Immunogenicity of Various Do Rheumatoid Arthritis | Phase 3 | 2022-12-07 |
| Unknown | A Double-Blind, Comparative, Randomized Clinical Study of the Pharmacokinetics, Safety, and Immunogenicity of Breast Cancer | Phase 1 | 2022-08-08 |
| Active Not Recruiting | A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy Melanoma, Melanoma (Skin), Melanoma Stage III | Phase 3 | 2022-08-02 |
| Unknown | Clinical Study of the Efficacy and Safety of BCD-201 and Keytruda in Subjects With Advanced Melanoma Melanoma (Skin) | Phase 3 | 2022-07-18 |
| Active Not Recruiting | Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyl Axial Spondyloarthritis | Phase 2 | 2022-04-19 |
| Completed | An Extension Clinical Study of the Efficacy and Safety of BCD-132 in Patients With Multiple Sclerosis Who Prev Multiple Sclerosis | Phase 3 | 2022-03-22 |
| Unknown | Prolgolimab 250 mg Q3W in Patients With Unresectable or Metastatic Melanoma Unresectable or Metastatic Melanoma | Phase 3 | 2022-02-01 |
| Unknown | Phase 1 Study of BCD-245 in Subjects With Neuroblastoma Neuroblastoma | Phase 1 | 2021-11-29 |
| Terminated | Clinical Study of the Safety and Immunogenicity of a Recombinant Viral Vector AAV5 (Adeno-Associated Virus Typ Coronavirus Infection, COVID-19 | Phase 1 / Phase 2 | 2021-08-10 |
| Completed | An International, Multicenter, Randomized, Double-Blind, Double-Masked Study of the Efficacy and Safety of BCD Multiple Sclerosis | Phase 3 | 2021-04-05 |
| Unknown | Clinical Trial to Evaluate the PK and Safety of BCD-201 and Keytruda® in Patients With Advanced Malignancies Melanoma, Non Small Cell Lung Cancer | Phase 1 | 2021-02-08 |
| Completed | Study of the Pharmacodynamics, Pharmacokinetics, Safety, and Immunogenicity of Single Escalating Doses of BCD- Healthy | Phase 1 | 2021-01-22 |
| Unknown | DEFENDOR: A Multicenter Prospective Observational Post-registration stuDy of Extimia® (INN: empEgfilrastim) to Patients With Solid Tumours Who Receive Myelosupressive Therapy | — | 2021-01-12 |
| Completed | A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19 COVID-19 | Phase 3 | 2020-04-29 |
| Completed | An Extension Clinical Study of BCD-148 for the Treatment of Patients With PNH Previously Treated in Clinical S Paroxysmal Nocturnal Hemoglobinuria (PNH) | Phase 3 | 2020-04-13 |
| Completed | Study of the Efficacy and Safety of BCD-089 in Combination With Methotrexate in Patients With Active Rheumatoi Rheumatoid Arthritis | Phase 3 | 2019-11-19 |
| Unknown | Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy With and Without Be Cervical Cancer | Phase 3 | 2019-10-01 |
| Unknown | Study of Efficacy and Safety of BCD-217 (Anti-CTLA-4 and Anti-PD-1) Followed By BCD-100 (Anti-PD-1) Versus BCD Melanoma, Melanoma Metastatic | Phase 2 | 2019-07-01 |
| Completed | Comparative Study of the Efficacy and Safety of BCD-132 With Teriflunomide and Placebo in Multiple Sclerosis Multiple Sclerosis | Phase 2 | 2019-06-07 |
| Unknown | Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treat Non-Squamous Non-Small Cell Neoplasm of Lung | Phase 3 | 2019-06-01 |
| Completed | Clinical Trial of BCD-148 and Soliris® for the Treatment of Patients With Paroxysmal Nocturnal Hemoglobinuria Paroxysmal Nocturnal Hemoglobinuria | Phase 3 | 2019-04-04 |
| Completed | First-In-Human Study to Evaluate Safety And Pharmacokinetics of Single Escalating Doses of BCD-147 (Bispecific Healthy | Phase 1 | 2019-01-30 |
| Unknown | Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Cervical Cancer, Cervical Cancer Metastatic, Cervical Cancer Recurrent | Phase 2 | 2018-12-25 |
| Completed | Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Dose Healthy Subjects | Phase 1 | 2018-09-21 |
| Completed | Clinical Study of Efficacy and Safety of BCD-085 (Monoclonal Anti-IL-17 Antibody) in Psoriatic Arthritis Psoriatic Arthritis | Phase 3 | 2018-07-25 |
| Terminated | Non-comparative Study of BCD-085 in Combination With UDCA in Patients With Primary Biliary Cholangitis Liver Cirrhosis, Biliary | Phase 2 | 2018-04-27 |
| Completed | Dose Escalation Study of the Pharmacodynamics, Pharmacokinetics, Safety, and Immunogenicity of BCD-132 in Pati Multiple Sclerosis | Phase 1 | 2018-02-22 |
| Completed | International Multicenter Comparative Randomized Placebo-controlled Clinical Study of Efficacy and Safety of B Ankylosing Spondylitis | Phase 3 | 2018-02-09 |
| Completed | The BCD-089 (aIL6R) in Patients With Active Rheumatoid Arthritis Seropositive RA | Phase 2 | 2018-02-01 |
| Completed | An International Multicenter, Randomized, Double-blind, Placebo-Controlled Clinical Study of Efficacy and Safe Moderate to Severe Plaque Psoriasis | Phase 3 | 2017-12-26 |
| Unknown | A Study of BCD-135 in Patients With Advanced Solid Tumors Melanoma, NSCLC, Renal Cell Carcinoma | Phase 1 | 2017-10-31 |
| Completed | Comparative Study of the Efficacy and Safety of BCD-131 and Mircera in Treatment of Anemia in CKD Patients on Anemia | Phase 2 | 2017-10-24 |
| Completed | Phase I Study of BCD-145 (Anti-CTLA-4) in Patients With Unresectable/Metastatic Melanoma Melanoma | Phase 1 | 2017-10-02 |
| Unknown | Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients Non Small Cell Lung Cancer Stage IIIB, Non-Small Cell Carcinoma of Lung, TNM Stage 4 | Phase 2 / Phase 3 | 2017-09-19 |
| Unknown | International Trial of the Efficacy and Safety of BCD-100 in Patients With Melanoma Melanoma | Phase 2 | 2017-08-31 |
| Completed | Comparative Clinical Trial to Evaluate Efficacy, Safety and Tolerance of BCD-054 and Avonex® for Treatment of Multiple Sclerosis, Relapsing-Remitting | Phase 2 / Phase 3 | 2017-08-10 |
| Completed | The Study of PK, PD, Safety of Multiple Intravenous Injections of BCD-066 and Aranesp in Healthy Volunteers Healthy | Phase 1 | 2017-03-28 |
| Completed | Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe P Psoriasis | Phase 3 | 2016-12-01 |
| Completed | First-in-human Study of Safety, Pharmacokinetics and Pharmacodynamics of Various Doses of BCD-089 in Healthy S Healthy | Phase 1 | 2016-11-01 |
| Completed | First-in-human Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Doses Healthy | Phase 1 | 2016-11-01 |
| Completed | Study of BCD-115 in Women With ER(+) HER2(-) Local Advanced and Metastatic Breast Cancer Breast Cancer | Phase 1 | 2016-11-01 |
| Completed | Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 Ankylosing Spondylitis | Phase 2 | 2016-09-01 |
| Unknown | A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumo Melanoma, Lung Cancer, Renal Cell Carcinoma | Phase 1 | 2016-08-30 |
| Completed | Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen® Leucocytosis | Phase 1 | 2016-07-18 |
| Completed | Study of Pharmacokinetics, Pharmacodynamics, Safety of BCD-131 Compared to Mircera and Aranesp in Healthy Volu Reticulocyte Count | Phase 1 | 2016-06-15 |
| Completed | International Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Psoriasis | Phase 2 | 2016-06-01 |
| Completed | Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosin Ankylosing Spondylitis | Phase 3 | 2016-01-01 |
| Completed | Comparative Clinical Trial of Efficacy and Safety of BCD-055 and Remicade® in Combination With Methotrexate in Rheumatoid Arthritis | Phase 3 | 2016-01-01 |
| Completed | Safety and Efficacy Study of BCD-066 Compared to Aranesp® for Anemia Treatment in Chronic Kidney Disease Patie Chronic Kidney Disease, End Stage Renal Failure on Dialysis, Anemia | Phase 3 | 2015-08-08 |
| Completed | Comparative Clinical Study of Pharmacokinetics, Tolerance and Safety of BCD-057 and Humira in Healthy Voluntee Healthy | Phase 1 | 2015-06-01 |
| Completed | First-in-human Study to Evaluate Safety, Tolerability and Pharmacokinetics of Various Doses of BCD-085 in Heal Healthy | Phase 1 | 2015-03-01 |
| Completed | Study of Efficacy and Safety of Drugs BCD-033 and Rebif for Treatment of Patients With Multiple Sclerosis Multiple Sclerosis | Phase 2 / Phase 3 | 2015-02-12 |
| Completed | Comparative Evaluation of Pharmacokinetics and Safety of BCD-055 and Remicade in Patients With Ankylosing Spon Ankylosing Spondylitis | Phase 1 | 2015-02-01 |
| Completed | Clinical Trial to Evaluate Efficacy and Safety of Acellbia® (JSC "BIOCAD") With Methotrexate in First Line Bio Rheumatoid Arthritis | Phase 3 | 2015-01-01 |
| Completed | A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic S Deep Vein Thrombosis | Phase 3 | 2015-01-01 |
| Completed | Open Label Study of Tolerability, Pharmacokinetics and Pharmacodynamics of BCD-054 (Pegylated Interferon Beta- Healthy | Phase 1 | 2014-07-01 |
| Completed | Efficacy and Safety of BCD-063 and Copaxone-Teva in Patients With Relapsing-Remitting Multiple Sclerosis Relapsing-remitting Multiple Sclerosis | Phase 3 | 2013-10-01 |
| Completed | Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients Chemotherapy-induced Neutropenia | Phase 3 | 2013-09-01 |
| Completed | An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Pa Hepatitis, Hepatitis C | Phase 3 | 2013-07-10 |
| Completed | An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepegi Hepatitis, Hepatitis C, Hepatitis C/ Human Immunodeficiency Virus Coinfection | Phase 3 | 2013-06-06 |
| Completed | Pharmacokinetics and Pharmacodynamics Study of BCD-066 Compared to Aranesp® in Healthy Volunteers Healthy | Phase 1 | 2013-03-01 |
| Completed | Pharmacokinetics and Pharmacodynamics Study of BCD-033 Compared to Rebif® in Healthy Volunteers Healthy | Phase 1 | 2013-02-01 |
| Completed | Study of Safety and Efficacy of BCD-020 Comparing to MabThera in Patients With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 3 | 2012-12-01 |
| Completed | A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Non-small Cell Lung Cancer | Phase 3 | 2012-10-01 |
| Completed | A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastat Human Epithelial Receptor (HER)-2 Positive Breast Cancer | Phase 3 | 2012-10-01 |
| Completed | Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer Chemotherapy-induced Neutropenia | Phase 2 | 2012-05-01 |
| Completed | Algeron (Cepeginterferon Alfa-2b) Compared With PegIntron (Peginterferon Alfa-2b) for Treatment of Chronic Hep Hepatitis, Hepatitis C | Phase 2 / Phase 3 | 2011-11-01 |
| Completed | Safety and Efficacy Study of BCD-020 in Therapy of Indolent Non-Hodgkin's Lymphoma Follicular Non-Hodgkin's Lymphoma, Nodal Marginal Zone Lymphoma, Splenic Marginal Zone Lymphoma | Phase 3 | 2011-09-01 |
| Withdrawn | Evaluation the Pharmacokinetics, Safety, Tolerability of BCD-021 in Patients With Neovascular Age-related Macu Neovascular Age-related Macular Degeneration | Phase 1 | — |
| Withdrawn | Safety and Efficacy Study of BCD-021 Compared to Lucentis® in Patients With Neovascular Wet Age-related Macula Wet Age-related Macular Degeneration | Phase 3 | — |